Zoely (nomegestrol/estradiol) / Merck (MSD) 
Welcome,         Profile    Billing    Logout  
 0 Diseases   2 Trials   2 Trials   50 News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zoely (nomegestrol/estradiol) / Merck (MSD)
2006-001546-14: A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE).

Ongoing
3
48
Europe
NOMAC-E2, Org 10486-0 + Org 2317, Yasmin 28, Yasmin 28
NV Organon
Hormonal oral contraception in healthy women
 
 
NCT05264506: Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive

Terminated
3
2007
US
NOMAC-E2 COC, Nomegestrol acetate / estradiol
Organon and Co, IQVIA Inc., OSTAtistics
Contraception
01/24
01/24
ACTRN12623000496617: Zoely vs. Zoloft in Premenstrual Dysphoric Disorder

Recruiting
2
160
 
Monash University, Monash University
premenstrual dysphoric disorder
 
 

Download Options